Treatment response assessment of breast masses on dynamic contrast-enhanced magnetic resonance scans using fuzzy
暂无分享,去创建一个
Lubomir M. Hadjiiski | H. Chan | M. Helvie | B. Sahiner | L. Hadjiiski | Jiazheng Shi | C. Paramagul | T. Chenevert
[1] Hon J. Yu,et al. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy , 2007, Journal of magnetic resonance imaging : JMRI.
[2] M D Schnall,et al. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. , 2001, Radiology.
[3] Lubomir M. Hadjiiski,et al. Characterization of mammographic masses based on level set segmentation with new image features and patient information. , 2007, Medical physics.
[4] Andrea Schenone,et al. A fuzzy clustering based segmentation system as support to diagnosis in medical imaging , 1999, Artif. Intell. Medicine.
[5] C. Kuhl. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.
[6] B. Asselain,et al. Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial , 1999, Breast Cancer Research and Treatment.
[7] L. Esserman,et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. , 2005, AJR. American journal of roentgenology.
[8] Richard C. Pais,et al. Evaluation of Lung MDCT Nodule Annotation Across Radiologists and Methods 1 , 2006 .
[9] Ying Lu,et al. MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer , 2001, Annals of Surgical Oncology.
[10] Kecheng Liu,et al. Shape recovery algorithms using level sets in 2-D/3-D medical imagery: a state-of-the-art review , 2002, IEEE Transactions on Information Technology in Biomedicine.
[11] Donald S. Fussell,et al. Interactive lesion segmentation on dynamic contrast enhanced breast MRI using a Markov model , 2006, SPIE Medical Imaging.
[12] T. Powles,et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] M. Giger,et al. A fuzzy c-means (FCM)-based approach for computerized segmentation of breast lesions in dynamic contrast-enhanced MR images. , 2006, Academic radiology.
[14] Thomas Bülow,et al. Segmentation of suspicious lesions in dynamic contrast-enhanced breast MR images , 2007, SPIE Medical Imaging.
[15] Mark A. Helvie,et al. Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy , 2005, Breast Cancer Research and Treatment.
[16] Anna L. Brown,et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Natal A W van Riel,et al. On the identifiability of pharmacokinetic parameters in dynamic contrast‐enhanced imaging , 2007, Magnetic resonance in medicine.
[18] Fabian Kiessling,et al. Determination of Pharmacokinetic Parameters in DCE MRI: Consequence of Nonlinearity Between Contrast Agent Concentration and Signal Intensity , 2006, Investigative radiology.
[19] C. Kuhl. Current status of breast MR imaging. Part 2. Clinical applications. , 2007, Radiology.
[20] Tanja Alderliesten,et al. Validation of Semiautomatic Measurement of the Extent of Breast Tumors Using Contrast-Enhanced Magnetic Resonance Imaging , 2007, Investigative radiology.
[21] B. Szabó,et al. Neural network approach to the segmentation and classification of dynamic magnetic resonance images of the breast: comparison with empiric and quantitative kinetic parameters. , 2004, Academic radiology.
[22] H. Putter,et al. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 , 2009, Breast Cancer Research and Treatment.
[23] M. Dewhirst,et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. , 2003, AJR. American journal of roentgenology.
[24] T. Powles,et al. Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] Michael Brady,et al. Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast , 2005, Medical Image Anal..
[26] Dianne Georgian-Smith,et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. , 2005, AJR. American journal of roentgenology.
[27] Carmel Hayes,et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. , 2006, Radiology.
[28] William M. Wells,et al. Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation , 2004, IEEE Transactions on Medical Imaging.
[29] U Sinha,et al. Segmentation strategies for breast tumors from dynamic MR images , 1996, Journal of magnetic resonance imaging : JMRI.
[30] M. Christian,et al. [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.
[31] Kelly K. Hunt,et al. A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility , 2002, Annals of Surgical Oncology.
[32] Wendy B DeMartini,et al. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. , 2007, Radiology.